The efficacy of a trivalent inactivated salmonella vaccine combined with the live s. gallinarum 9R vaccine in young layers after experimental infections with s. enteritidis, s. typ...

Autores
Huberman, Yosef Daniel; Caballero García, Melanie; Rojas, Rober; Ascanio, Silvia.; Olmos, Leandro Hipolito; Malena, Rosana Claudia; Lomonaco, Jorgelina; Nievas, Paula Andrea; Chero, Paula; Lévano Gracía, Julio; Mendoza Espinoza, Alfredo
Año de publicación
2022
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Worldwide, poultry infections by Salmonella are the cause of significant economic losses, not only due to reduced production (due to fowl typhoid disease), but also considering the efforts and control measures that must be constantly applied, especially due to zoonotic serovars. Poultry is a common reservoir of Salmonella and its transmission into the food chain is a risk for humans. The vaccination of layers plays an important role in the overall efforts to prevent Salmonella infections. An inactivated trivalent vaccine was prepared with S. Enteritidis, S. Typhimurium, and S. Infantis strains. Infection trials were performed to evaluate the efficacy of three vaccination schedules using inactivated and live S. Gallinarum 9R vaccines. For this purpose, at week 5 of life, one subcutaneous dose of live S. Gallinarum 9R vaccine (1–5 × 107 CFU) was given to Groups 1 and 2. At weeks 8 and 11 of life, chickens were also vaccinated with one (Group 1) or two (Groups 2 and 3) intramuscular doses of the inactivated oil-adjuvant trivalent vaccine (1 × 108 CFU/dose of each antigen). Group 4 consisted of chickens that remained unvaccinated (control). At week 14 of life, the efficacy of the vaccination plans was evaluated in three separate inoculation trials with S. Enteritidis, S. Typhimurium, or S. Infantis. After vaccination with the inactivated vaccine, homologous antibody production was observed, and after challenge, a significant reduction in the faecal shedding, invasion, and colonization of S. Typhimurium and S. Infantis was achieved by all vaccination schedules, while the vaccination with at least one dose of the live S. Gallinarum 9R vaccine was necessary to obtain such a significant protection against S. Enteritidis infection.
EEA Balcarce
Fil: Huberman, Yosef Daniel. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.
Fil: Caballero Garcia, Melanie. Quimtia. Research and Development; Perú.
Fil: Rojas, Rober. Quimtia. Research and Development; Perú.
Fil: Ascanio, Silvia. Quimtia. Research and Development; Perú.
Fil: Olmos, Leandro Hipólito. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.
Fil: Malena, Rosana Claudia. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.
Fil: Lomónaco, Jorgelina. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.
Fil: Nievas, Paula Andrea. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.
Fil: Chero, Paula. Quimtia. Research and Development; Perú.
Fil: Lévano Gracía, Julio. Quimtia. Research and Development; Perú.
Fil: Mendoza Espinoza, Alfredo. Quimtia. Research and Development; Perú.
Fuente
Vaccines 10 (7) : 1113 (July 2022)
Materia
Pollo
Vacuna Inactivada
Salmonella
Salmonella Enteritidis
Salmonella Typhimurium
Chickens
Inactivated Vaccines
Salmonella Infantis
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by-nc-sa/4.0/
Repositorio
INTA Digital (INTA)
Institución
Instituto Nacional de Tecnología Agropecuaria
OAI Identificador
oai:localhost:20.500.12123/12505

id INTADig_285865410527a201dcdc711a5dad4c20
oai_identifier_str oai:localhost:20.500.12123/12505
network_acronym_str INTADig
repository_id_str l
network_name_str INTA Digital (INTA)
spelling The efficacy of a trivalent inactivated salmonella vaccine combined with the live s. gallinarum 9R vaccine in young layers after experimental infections with s. enteritidis, s. typhimurium, and s. infantisHuberman, Yosef DanielCaballero García, MelanieRojas, RoberAscanio, Silvia.Olmos, Leandro HipolitoMalena, Rosana ClaudiaLomonaco, JorgelinaNievas, Paula AndreaChero, PaulaLévano Gracía, JulioMendoza Espinoza, AlfredoPolloVacuna InactivadaSalmonellaSalmonella EnteritidisSalmonella TyphimuriumChickensInactivated VaccinesSalmonella InfantisWorldwide, poultry infections by Salmonella are the cause of significant economic losses, not only due to reduced production (due to fowl typhoid disease), but also considering the efforts and control measures that must be constantly applied, especially due to zoonotic serovars. Poultry is a common reservoir of Salmonella and its transmission into the food chain is a risk for humans. The vaccination of layers plays an important role in the overall efforts to prevent Salmonella infections. An inactivated trivalent vaccine was prepared with S. Enteritidis, S. Typhimurium, and S. Infantis strains. Infection trials were performed to evaluate the efficacy of three vaccination schedules using inactivated and live S. Gallinarum 9R vaccines. For this purpose, at week 5 of life, one subcutaneous dose of live S. Gallinarum 9R vaccine (1–5 × 107 CFU) was given to Groups 1 and 2. At weeks 8 and 11 of life, chickens were also vaccinated with one (Group 1) or two (Groups 2 and 3) intramuscular doses of the inactivated oil-adjuvant trivalent vaccine (1 × 108 CFU/dose of each antigen). Group 4 consisted of chickens that remained unvaccinated (control). At week 14 of life, the efficacy of the vaccination plans was evaluated in three separate inoculation trials with S. Enteritidis, S. Typhimurium, or S. Infantis. After vaccination with the inactivated vaccine, homologous antibody production was observed, and after challenge, a significant reduction in the faecal shedding, invasion, and colonization of S. Typhimurium and S. Infantis was achieved by all vaccination schedules, while the vaccination with at least one dose of the live S. Gallinarum 9R vaccine was necessary to obtain such a significant protection against S. Enteritidis infection.EEA BalcarceFil: Huberman, Yosef Daniel. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.Fil: Caballero Garcia, Melanie. Quimtia. Research and Development; Perú.Fil: Rojas, Rober. Quimtia. Research and Development; Perú.Fil: Ascanio, Silvia. Quimtia. Research and Development; Perú.Fil: Olmos, Leandro Hipólito. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.Fil: Malena, Rosana Claudia. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.Fil: Lomónaco, Jorgelina. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.Fil: Nievas, Paula Andrea. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.Fil: Chero, Paula. Quimtia. Research and Development; Perú.Fil: Lévano Gracía, Julio. Quimtia. Research and Development; Perú.Fil: Mendoza Espinoza, Alfredo. Quimtia. Research and Development; Perú.MDPI2022-08-05T11:13:38Z2022-08-05T11:13:38Z2022-07-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://hdl.handle.net/20.500.12123/12505https://www.mdpi.com/2076-393X/10/7/11132076-393Xhttps://doi.org/10.3390/vaccines10071113Vaccines 10 (7) : 1113 (July 2022)reponame:INTA Digital (INTA)instname:Instituto Nacional de Tecnología Agropecuariaenginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)2025-09-29T13:45:39Zoai:localhost:20.500.12123/12505instacron:INTAInstitucionalhttp://repositorio.inta.gob.ar/Organismo científico-tecnológicoNo correspondehttp://repositorio.inta.gob.ar/oai/requesttripaldi.nicolas@inta.gob.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:l2025-09-29 13:45:39.556INTA Digital (INTA) - Instituto Nacional de Tecnología Agropecuariafalse
dc.title.none.fl_str_mv The efficacy of a trivalent inactivated salmonella vaccine combined with the live s. gallinarum 9R vaccine in young layers after experimental infections with s. enteritidis, s. typhimurium, and s. infantis
title The efficacy of a trivalent inactivated salmonella vaccine combined with the live s. gallinarum 9R vaccine in young layers after experimental infections with s. enteritidis, s. typhimurium, and s. infantis
spellingShingle The efficacy of a trivalent inactivated salmonella vaccine combined with the live s. gallinarum 9R vaccine in young layers after experimental infections with s. enteritidis, s. typhimurium, and s. infantis
Huberman, Yosef Daniel
Pollo
Vacuna Inactivada
Salmonella
Salmonella Enteritidis
Salmonella Typhimurium
Chickens
Inactivated Vaccines
Salmonella Infantis
title_short The efficacy of a trivalent inactivated salmonella vaccine combined with the live s. gallinarum 9R vaccine in young layers after experimental infections with s. enteritidis, s. typhimurium, and s. infantis
title_full The efficacy of a trivalent inactivated salmonella vaccine combined with the live s. gallinarum 9R vaccine in young layers after experimental infections with s. enteritidis, s. typhimurium, and s. infantis
title_fullStr The efficacy of a trivalent inactivated salmonella vaccine combined with the live s. gallinarum 9R vaccine in young layers after experimental infections with s. enteritidis, s. typhimurium, and s. infantis
title_full_unstemmed The efficacy of a trivalent inactivated salmonella vaccine combined with the live s. gallinarum 9R vaccine in young layers after experimental infections with s. enteritidis, s. typhimurium, and s. infantis
title_sort The efficacy of a trivalent inactivated salmonella vaccine combined with the live s. gallinarum 9R vaccine in young layers after experimental infections with s. enteritidis, s. typhimurium, and s. infantis
dc.creator.none.fl_str_mv Huberman, Yosef Daniel
Caballero García, Melanie
Rojas, Rober
Ascanio, Silvia.
Olmos, Leandro Hipolito
Malena, Rosana Claudia
Lomonaco, Jorgelina
Nievas, Paula Andrea
Chero, Paula
Lévano Gracía, Julio
Mendoza Espinoza, Alfredo
author Huberman, Yosef Daniel
author_facet Huberman, Yosef Daniel
Caballero García, Melanie
Rojas, Rober
Ascanio, Silvia.
Olmos, Leandro Hipolito
Malena, Rosana Claudia
Lomonaco, Jorgelina
Nievas, Paula Andrea
Chero, Paula
Lévano Gracía, Julio
Mendoza Espinoza, Alfredo
author_role author
author2 Caballero García, Melanie
Rojas, Rober
Ascanio, Silvia.
Olmos, Leandro Hipolito
Malena, Rosana Claudia
Lomonaco, Jorgelina
Nievas, Paula Andrea
Chero, Paula
Lévano Gracía, Julio
Mendoza Espinoza, Alfredo
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Pollo
Vacuna Inactivada
Salmonella
Salmonella Enteritidis
Salmonella Typhimurium
Chickens
Inactivated Vaccines
Salmonella Infantis
topic Pollo
Vacuna Inactivada
Salmonella
Salmonella Enteritidis
Salmonella Typhimurium
Chickens
Inactivated Vaccines
Salmonella Infantis
dc.description.none.fl_txt_mv Worldwide, poultry infections by Salmonella are the cause of significant economic losses, not only due to reduced production (due to fowl typhoid disease), but also considering the efforts and control measures that must be constantly applied, especially due to zoonotic serovars. Poultry is a common reservoir of Salmonella and its transmission into the food chain is a risk for humans. The vaccination of layers plays an important role in the overall efforts to prevent Salmonella infections. An inactivated trivalent vaccine was prepared with S. Enteritidis, S. Typhimurium, and S. Infantis strains. Infection trials were performed to evaluate the efficacy of three vaccination schedules using inactivated and live S. Gallinarum 9R vaccines. For this purpose, at week 5 of life, one subcutaneous dose of live S. Gallinarum 9R vaccine (1–5 × 107 CFU) was given to Groups 1 and 2. At weeks 8 and 11 of life, chickens were also vaccinated with one (Group 1) or two (Groups 2 and 3) intramuscular doses of the inactivated oil-adjuvant trivalent vaccine (1 × 108 CFU/dose of each antigen). Group 4 consisted of chickens that remained unvaccinated (control). At week 14 of life, the efficacy of the vaccination plans was evaluated in three separate inoculation trials with S. Enteritidis, S. Typhimurium, or S. Infantis. After vaccination with the inactivated vaccine, homologous antibody production was observed, and after challenge, a significant reduction in the faecal shedding, invasion, and colonization of S. Typhimurium and S. Infantis was achieved by all vaccination schedules, while the vaccination with at least one dose of the live S. Gallinarum 9R vaccine was necessary to obtain such a significant protection against S. Enteritidis infection.
EEA Balcarce
Fil: Huberman, Yosef Daniel. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.
Fil: Caballero Garcia, Melanie. Quimtia. Research and Development; Perú.
Fil: Rojas, Rober. Quimtia. Research and Development; Perú.
Fil: Ascanio, Silvia. Quimtia. Research and Development; Perú.
Fil: Olmos, Leandro Hipólito. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.
Fil: Malena, Rosana Claudia. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.
Fil: Lomónaco, Jorgelina. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.
Fil: Nievas, Paula Andrea. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina.
Fil: Chero, Paula. Quimtia. Research and Development; Perú.
Fil: Lévano Gracía, Julio. Quimtia. Research and Development; Perú.
Fil: Mendoza Espinoza, Alfredo. Quimtia. Research and Development; Perú.
description Worldwide, poultry infections by Salmonella are the cause of significant economic losses, not only due to reduced production (due to fowl typhoid disease), but also considering the efforts and control measures that must be constantly applied, especially due to zoonotic serovars. Poultry is a common reservoir of Salmonella and its transmission into the food chain is a risk for humans. The vaccination of layers plays an important role in the overall efforts to prevent Salmonella infections. An inactivated trivalent vaccine was prepared with S. Enteritidis, S. Typhimurium, and S. Infantis strains. Infection trials were performed to evaluate the efficacy of three vaccination schedules using inactivated and live S. Gallinarum 9R vaccines. For this purpose, at week 5 of life, one subcutaneous dose of live S. Gallinarum 9R vaccine (1–5 × 107 CFU) was given to Groups 1 and 2. At weeks 8 and 11 of life, chickens were also vaccinated with one (Group 1) or two (Groups 2 and 3) intramuscular doses of the inactivated oil-adjuvant trivalent vaccine (1 × 108 CFU/dose of each antigen). Group 4 consisted of chickens that remained unvaccinated (control). At week 14 of life, the efficacy of the vaccination plans was evaluated in three separate inoculation trials with S. Enteritidis, S. Typhimurium, or S. Infantis. After vaccination with the inactivated vaccine, homologous antibody production was observed, and after challenge, a significant reduction in the faecal shedding, invasion, and colonization of S. Typhimurium and S. Infantis was achieved by all vaccination schedules, while the vaccination with at least one dose of the live S. Gallinarum 9R vaccine was necessary to obtain such a significant protection against S. Enteritidis infection.
publishDate 2022
dc.date.none.fl_str_mv 2022-08-05T11:13:38Z
2022-08-05T11:13:38Z
2022-07-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12123/12505
https://www.mdpi.com/2076-393X/10/7/1113
2076-393X
https://doi.org/10.3390/vaccines10071113
url http://hdl.handle.net/20.500.12123/12505
https://www.mdpi.com/2076-393X/10/7/1113
https://doi.org/10.3390/vaccines10071113
identifier_str_mv 2076-393X
dc.language.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv Vaccines 10 (7) : 1113 (July 2022)
reponame:INTA Digital (INTA)
instname:Instituto Nacional de Tecnología Agropecuaria
reponame_str INTA Digital (INTA)
collection INTA Digital (INTA)
instname_str Instituto Nacional de Tecnología Agropecuaria
repository.name.fl_str_mv INTA Digital (INTA) - Instituto Nacional de Tecnología Agropecuaria
repository.mail.fl_str_mv tripaldi.nicolas@inta.gob.ar
_version_ 1844619167718703104
score 12.558318